Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-12,730
Closed -$3.47K 1911
2026
Q1
$3.47K Sell
12,730
-36,129
-74% -$14.9K ﹤0.01% 1488
2025
Q4
$27.5K Hold
48,859
﹤0.01% 1465
2025
Q3
$70.8K Buy
+48,859
New +$87.2K ﹤0.01% 1447
2024
Q2
Sell
-24,412
Closed -$267K 1831
2024
Q1
$267K Buy
+24,412
New +$146K ﹤0.01% 1289
2023
Q1
Sell
-74,855
Closed -$370K 2014
2022
Q4
$370K Buy
+74,855
New +$931K 0.01% 1288
2022
Q1
Sell
-18,330
Closed -$771K 2531
2021
Q4
$771K Buy
+18,330
New +$820K 0.01% 1204
2021
Q3
Sell
-13,587
Closed -$363K 2470
2021
Q2
$363K Buy
+13,587
New +$340K ﹤0.01% 1625

Other funds holding NOTV

Michael Gelband's NOTV Position: Q2 2026 in Review

Michael Gelband sold out of Inotiv (NOTV) in Q2 2026, closing a stake of 12,730 shares — an estimated $3.47K sold.

Michael Gelband first reported a position in NOTV in Q2 2021 and held it in 7 quarters. The position peaked at $771K in Q4 2021. 3 funds tracked by Wall St. Rank hold NOTV as of Q2 2026.

  • Michael Gelband reported no remaining Inotiv position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 12,730 Inotiv shares in Q2 2026, an estimated $3.47K.
  • Michael Gelband first reported a position in Inotiv in Q2 2021 and held it in 7 quarters.
  • Michael Gelband's Inotiv position peaked at $771K in Q4 2021.
  • 3 funds tracked by Wall St. Rank held Inotiv as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.